Engineering\CADD Systems Office CADD Manager's Series Printing.
Iview bioinformatics tool ....CADD/DOCKING
-
Upload
ayesha-aftab -
Category
Science
-
view
236 -
download
1
description
Transcript of Iview bioinformatics tool ....CADD/DOCKING
04/10/2023Free template from www.brainybetty.com 1
04/10/2023 2
AYESHA AFTAB MALIKKHADIJA IJAZZAHRA HANIF
DEPARTMENT OF BIOINFORMATICS AND TECHNOLOGYINTERNATIONAL ISLAMIC UNIVERSITY ISLAMABAD
04/10/2023 3
RESEARCH PAPER DETAILS
• NAME: IVIEW: AN INTERACTIVE WEBGL VISUALIZER FOR PROTEIN-LIGAND COMPLEX
• AUTHORS: HONG JIAN LI, KWONG-SAK LEUNG , TAKANORI NAKANE AND MAN-HON WONG , DEPARTMENT OF COMPUTER SCIENCE AND ENGINEERING, CHINESE UNIVERSITY OF HONG KONG, HONG KONG, CHINA. 2GRADUATE SCHOOL OF MEDICINE, KYOTO,UNIVERSITY, KYOTO, JAPAN.
• PUBLISHED IN: LI ET AL. BMC BIOINFORMATICS 2014
• 25 FEBRUARY 2014
• HTTP://WWW.BIOMEDCENTRAL.COM/1471-2105/15/56
IVIEW
04/10/2023 5
IVIEW
• AN INTERACTIVE WEBGL VISUALIZER FOR PROTEIN-LIGAND COMPLEX SOFTWARE.
04/10/2023 6
BACKGROUND
Free template from www.brainybetty.com 7
WHY VISUALIZATION TOOL IS IMPORTANT?
PROTEIN-LIGAND COMPLEX PLAYS AN IMPORTANT ROLE IN
• ELABORATING PROTEIN-LIGAND INTERACTIONS
• AIDING NOVEL DRUG DESIGN.
04/10/2023 8
ALREADY EXISTING TOOLS
VISUALIZATION TOOLS:VMD,PYMOL
DOCKING TOOLS,AUTODOCK,AUTODOCK VINA , IDOCK
2D DIAGRAM PLOTTING TOOLS:POSEVIEW ,LIGPLOT
WEB VISUALIZERS:GIANT
CHEMINFORMATICS LIBRARY:CHEMDOODLEWEB COMPONENTS
MOLECULAR VIEWER: GLMOL
04/10/2023 9
DRAWBACKS OF EXISTING SOFTWARES
•SLOW SOFTWARE RENDERING
•LACK VIRTUAL REALITY SUPPORT.
•MACROMOLECULAR SURFACE CONSTRUCTION UNAVAILABLE.
•THE SUPPORT FOR PDBQT FORMAT IS NOT IMPLEMENTED.
04/10/2023 10
IMPLEMENTATION
04/10/2023 11
FILE FORMAT INPUT
PDB
PDBQT
04/10/2023 12
FEATURES
• CAMERA
• BACKGROUND
04/10/2023 13
CAMERA
PERSPECTIVE
ORTHOGRAPHIC
04/10/2023 14
CAMERA PERSPECTIVE
04/10/2023 15
ORTHOGRAPHIC
04/10/2023 16
BACKGROUND
BLACK
GREY
WHITE
04/10/2023 17
GREY
04/10/2023 18
WHITE
04/10/2023 19
STRUCTURE COLORING
ATOM SPECTRUM
PROTEIN CHAIN
PROTEIN SECONDARY STRUCTURE
B FACTOR
RESIDUE NAME
RESIDUE POLARITY
ATOM TYPE
04/10/2023 20
PRIMARY STRUCTURE
LINE
STICK
BALL & STICK
SPHERE
DOT
04/10/2023Free template from www.brainybetty.com 21
PRIMARY STRUCTURE AS LINE
04/10/2023Free template from www.brainybetty.com 22
PRIMARY STRUCTURE AS STICK
04/10/2023 23
PRIMARY STRUCTURE AS BALL AND STICK
04/10/2023Free template from www.brainybetty.com 24
DISPLAY IONS AS SPHERE
04/10/2023Free template from www.brainybetty.com 25
IONS AS DOT
04/10/2023 26
SECONDARY STRUCTURE RIBBON
STRAND
CYLINDER & PLATE
C ALPHA TRACE
B FACTOR TUBE
04/10/2023Free template from www.brainybetty.com 27
SECONDARY STRUCTURE AS RIBBON
04/10/2023 28
SECONDARY STRUCTURE AS STRAND
04/10/2023 29
SECONDARY STRUCTURE AS CYLINDER AND PLATE
04/10/2023 30
C ALPHA TRACE
04/10/2023 31
B FACTOR TUBE
04/10/2023 32
PROTEIN SURFACE
VAN DER WAALS SURFACE
SOLVENT EXCLUDED SURFACE
SOLVENT ACCESSIBLE SURFACE
MOLECULAR SURFACE
04/10/2023 33
VANDER WALLS SURFACE
04/10/2023 34
SOLVENT EXCLUDED SURFACE
04/10/2023 35
SOLVENT ACCESSIBLE SURFACE
04/10/2023 36
MOLECULAR SURFACE
04/10/2023 37
PROTEINS SURFACE OPACITY
1.0
0.9
0.8
0.7
0.6
0.5
04/10/2023 38
PROTEIN SURFACE WIREFRAME
YES
NO
04/10/2023 39
WITH WIRE FRAME WORK
04/10/2023 40
ATOM AND RESIDUE LABELING
YES
NO
04/10/2023 41
LABELLED RESIDUES
04/10/2023 42
LIGAND VISUALIZATION
• LINE
• STICK
• BALL AND STICK
• SPHERE
04/10/2023 43
LIGAND AS LINE
04/10/2023 44
LIGAND AS STICK
04/10/2023 45
LIGAND AS BALL AND STICK
04/10/2023 46
LIGAND AS SPHERE
04/10/2023 47
VIRTUAL REALITY EFFECT
ANAGLYPH
PARALLAX BARRIER
OCULUS RIFT
04/10/2023 48
ANAGLYPH
04/10/2023 49
PARALLAX BARRIER
04/10/2023Free template from www.brainybetty.com 50
OCULUS RIFT
04/10/2023 51
RESULTS
example the CCR5 chemokine receptor-HIV entry inhibitor maraviroc complex
04/10/2023 52
Figure shows the human CCR5 secondary structurerendered as ribbon, and the ligands rendered assphere.
04/10/2023 53
Figure shows the anaglyph effect in a virtual realityenvironment. When users wear a spectacle with specialfilters on both sides, the disparity between two superimposedmolecules creates a perception of depth, leading tovisually more appealing identification of intermolecularinteractions.
04/10/2023 54
Figure shows the protein surface generated by ourJavaScript implementation of the EDTSurf algorithm. The human CCR5 is rendered as molecular surface colored by chain. The marketed HIV drug maraviroc is rendered as stick colored by chain. It can be clearly seen that the asymmetric unit is composed of two complexes,and the CCR5 forms a deep allosteric cavity where maraviroc binds.
04/10/2023 55
successfully tested iview in: Chrome 30,Firefox 25Safari 6.1 Opera 17.Refer to http://caniuse.com/webgl, for compatibility of WebGL support in desktop and mobile browsers.
04/10/2023 56
CONCLUSION
04/10/2023 57
Iview is designed and developed to :
• Be a simple & straightforward way to visualize protein-ligand complex.
• enables non-experts to quickly elucidate protei-ligand interactions in a 3D manner.
• be a free and open source
• Easily integrated into any bioinformatics application that requires interactive protein-ligand visualization
04/10/2023 58
REFERENCES• HUMPHREY W, DALKE A, SCHULTEN K: VMD:
VISUALMOLECULAR DYNAMICS.
• JMOL GRAPH 1996, 14(1):33–38.
• 2. PETTERSEN EF, GODDARD TD, HUANG CC, COUCH GS, GREENBLATT D. M,
• MENG EC, FERRIN TE: UCSF CHIMERA - A VISUALIZATION SYSTEM FOR
• EXPLORATORY RESEARCH AND ANALYSIS. J COMPUT CHEM 2004,
• 25(13):1605–1612.
• 3. MORRIS GM, HUEY R, LINDSTROM W, SANNER MF, BELEW RK, GOODSELL DS,
• OLSON AJ: AUTODOCK4 AND AUTODOCKTOOLS4: AUTOMATED DOCKING WITH
• SELECTIVE RECEPTOR FLEXIBILITY. J COMPUT CHEM 2009, 30(16):2785–2791.
• 4. TROTT O, OLSON AJ: AUTODOCK VINA: IMPROVING THE SPEED AND ACCURACY
• OF DOCKING WITH A NEW SCORING FUNCTION, EFFICIENT OPTIMIZATION, AND
• MULTITHREADING. J COMPUT CHEM 2010, 31(2):455–461.
• 5. LI H, LEUNG K-S, WONG M-H: IDOCK: AMULTITHREADED VIRTUAL SCREENING
• TOOL FOR FLEXIBLE LIGAND DOCKING. IN 2012 IEEE SYMPOSIUM ON
• COMPUTATIONAL INTELLIGENCE IN BIOINFORMATICS AND COMPUTATIONAL BIOLOGY
• (CIBCB). SAN DIEGO, CALIFORNIA, USA: IEEE; 2012:77–84.
[HTTP://IEEEXPLORE.
• IEEE.ORG/XPL/ARTICLEDETAILS.JSP?ARNUMBER=6217214]
• 6. TSE C-M, LI H, LEUNG K-S, LEE K-H, WONG M-H: INTERACTIVE DRUG DESIGN IN
• VIRTUAL REALITY. IN 15TH INTERNATIONAL CONFERENCE ON INFORMATION
• VISUALISATION (IV). LONDON, UK: IEEE; 2011:226–231. [HTTP://IEEEXPLORE.IEEE.
• ORG/XPL/ARTICLEDETAILS.JSP?ARNUMBER=6004005]
• 7. STIERAND K, RAREY M: POSEVIEW -MOLECULAR INTERACTION PATTERNS AT A
• GLANCE. J CHEMINFORM 2010, 2:50.
• 8. LASKOWSKI RA, SWINDELLS MB: LIGPLOT+:MULTIPLE LIGAND-PROTEIN
• INTERACTION DIAGRAMS FOR DRUG DISCOVERY. J CHEM INFORMMODELING 2011,
• 51(10):2778–2786.
• 9. KASAHARA K, KINOSHITA K: GIANT: PATTERN ANALYSIS OF MOLECULAR
• INTERACTIONS IN 3D STRUCTURES OF PROTEIN-SMALL LIGAND COMPLEXES.
• BMC BIOINFORMATICS 2014, 15(1):12.
• 10. HANSON RM, PRILUSKY J, RENJIAN Z, NAKANE T, SUSSMAN JL: JSMOL AND THE
• NEXT-GENERATION WEB-BASED REPRESENTATION OF 3DMOLECULAR
• STRUCTURE AS APPLIED TO PROTEOPEDIA. ISR J CHEM 2013, 53(3–4):207–216.
04/10/2023Free template from www.brainybetty.com 59
04/10/2023Free template from www.brainybetty.com 60